$BSPM: According to Zacks Investment Research, “
Post# of 23086
Posted On: 06/09/2016 5:15:29 PM
$BSPM: According to Zacks Investment Research, “BioStar Pharmaceuticals, Inc. (BSPM), through its wholly-owned subsidiary, Shaanxi Aoxing Pharmaceutical Co., Ltd., develops, manufactures and markets pharmaceutical and medical nutrient products for a variety of diseases and conditions. The Company’s most popular product is its Xin Ao Xing Oleanolic Acid Capsule, an over-the-counter medicine for chronic hepatitis B, a disease affecting approximately 10% of the Chinese population. In addition to its hepatitis product, Biostar manufactures two broad-based over-the-counter products, two prescription-based pharmaceuticals and ten nutrients. The Company has adopted international standards and is in the process of applying for three patents. It also operates an herbal medicine planting base which provides it with many of its needed materials at a significantly lower cost than purchasing from third parties, and eliminates most needs for transportation.”
With the drop of 19% today the stock looks very attractive now. BSPM was traded between $1 and $10 within last 12 months and the upside potential is very high from here.
http://hintsnewsnetwork.com/biostar-pharmaceu...ty/137182/
With the drop of 19% today the stock looks very attractive now. BSPM was traded between $1 and $10 within last 12 months and the upside potential is very high from here.
http://hintsnewsnetwork.com/biostar-pharmaceu...ty/137182/
(1)
(0)